270 related articles for article (PubMed ID: 4590191)
1. An outbreak of Sonne shigellosis in a population receiving oral attenuated shigella vaccines.
Levine MM; Rice PA; Gangarosa EJ; Morris GK; Snyder MJ; Formal SB; Wells JG; Gemski P; Hammond J
Am J Epidemiol; 1974 Jan; 99(1):30-6. PubMed ID: 4590191
[No Abstract] [Full Text] [Related]
2. Shigellosis in custodial institutions. 3. Prospective clinical and bacteriologic surveillance of children vaccinated with oral attenuated shigella vaccines.
Levine MM; Gangarosa EJ; Werner M; Morris GK
J Pediatr; 1974 Jun; 84(6):803-6. PubMed ID: 4596999
[No Abstract] [Full Text] [Related]
3. Live oral Shigella vaccine: vaccination schedule and the effect of booster dose.
Mel DM; Arsic BL; Radovanovic ML; Litvinjenko SA
Acta Microbiol Acad Sci Hung; 1974; 21(1-2):109-14. PubMed ID: 4613128
[No Abstract] [Full Text] [Related]
4. Self-experiments with ingestion of various bacteria.
Rédey B
Acta Microbiol Acad Sci Hung; 1974; 21(1-2):45-62. PubMed ID: 4216252
[No Abstract] [Full Text] [Related]
5. Technological aspect of the production of live dysentery vaccines for oral administration.
Denchev V; Nenkov P; Vitanov T; Sumerska T; Marinova S; Vassilev T; Panova I; Bratoeva M; Linde K
Acta Microbiol Hung; 1991; 38(2):121-6. PubMed ID: 1805499
[TBL] [Abstract][Full Text] [Related]
6. Shigellosis in custodial institutions. V. Effect of intervention with streptomycin-dependent Shigella sonnei vaccine in an institution with endemic disease.
Levine MM; Gangarosa EJ; Barrow WB; Weiss CF
Am J Epidemiol; 1976 Jul; 104(1):88-92. PubMed ID: 779465
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of a polyvalent protein-polysaccharide dysentery oral vaccine.
Zhang HM; Li YP; Song LH; Yu XL; Liu NH; Kong XE; Li L; Zhai YL
Chin Med J (Engl); 1987 May; 100(5):425-8. PubMed ID: 3115716
[No Abstract] [Full Text] [Related]
8. Auxotrophic live oral Shigella flexneri vaccine protects monkeys against challenge with S. flexneri of different serotypes.
Kärnell A; Sweiha H; Lindberg AA
Vaccine; 1992; 10(3):167-74. PubMed ID: 1557932
[TBL] [Abstract][Full Text] [Related]
9. Immunity in shigellosis. II. Protection induced by oral live vaccine or primary infection.
DuPont HL; Hornick RB; Snyder MJ; Libonati JP; Formal SB; Gangarosa EJ
J Infect Dis; 1972 Jan; 125(1):12-6. PubMed ID: 4550416
[No Abstract] [Full Text] [Related]
10. Study on the effect of oral immunization of T32-Istrati strain against bacillary dysentery in field trials.
Bingrui W
Arch Roum Pathol Exp Microbiol; 1984; 43(3-4):285-9. PubMed ID: 6400301
[No Abstract] [Full Text] [Related]
11. [Treatment of chronic bacillary dysentery using a live anti-dysentery vaccine].
Istrati G; Meitert T; Ciufercu C; Sulea IT; Baron E; Jipa G; Popescu P; Eduard H; Antonescu O; Frunzetti L; Dobrescu A; Sulutiu E; Ionescu L; Tilica D; Ghisoiu V; Brinzac V; Ceauşescu I; Bădescu M
Arch Roum Pathol Exp Microbiol; 1973 Mar; 32(1):22-33. PubMed ID: 4585402
[No Abstract] [Full Text] [Related]
12. Successful field trials with oral killed Shigella sonnei vaccine.
Grahneis H
Acta Microbiol Acad Sci Hung; 1974; 21(1-2):75-80. PubMed ID: 4613141
[No Abstract] [Full Text] [Related]
13. Shigellosis in custodial institutions. II. Clinical, immunologic and bacteriologic response of institutionalized children to oral attenuated shigella vaccines.
Levine MM; Dupont HL; Gangarosa EJ; Hornick RB; Snyder MJ; Libonati JP; Glaser K; Formal SB
Am J Epidemiol; 1972 Jul; 96(1):40-9. PubMed ID: 4557072
[No Abstract] [Full Text] [Related]
14. [Safety, reactivity and effectiveness testing of live shigella flexneri vaccines in laboratory animals and children (author's transl)].
Sergeev VV; Elkina SI; Solodnikov YP; Shuster BY; Sergeeva GS; Bulk VF; Bobkin SV
Acta Microbiol Acad Sci Hung; 1974; 21(1-2):121-8. PubMed ID: 4216247
[No Abstract] [Full Text] [Related]
15. Clinical trials of Shigella vaccines in Israel.
Cohen D; Ashkenazi S; Green M; Gdalevich M; Yavzori M; Orr N; Robin G; Slepon R; Lerman Y; Block C; Ashkenazi I; Taylor D; Hale L; Sadoff J; Schneerson R; Robbins J; Wiener M; Shemer J
Adv Exp Med Biol; 1996; 397():159-67. PubMed ID: 8718595
[No Abstract] [Full Text] [Related]
16. [Causes of sequential changes in the etiological structure of dysentery and the other epidemiologic patterns of this infection].
Avdeeva TA; Toluzakova NV; Kleganov VK
Zh Mikrobiol Epidemiol Immunobiol; 1983 May; (5):3-9. PubMed ID: 6349187
[No Abstract] [Full Text] [Related]
17. Oral shigella vaccines.
Hale TL; Formal SB
Curr Top Microbiol Immunol; 1989; 146():205-11. PubMed ID: 2659269
[No Abstract] [Full Text] [Related]
18. [Live shigella flexneri 2a and shigella sonnei vaccines (author's transl)].
Belaia IuA; Gekker VD; Kuz'min SN; Sergeeva NS
Acta Microbiol Acad Sci Hung; 1974; 21(1-2):63-9. PubMed ID: 4216253
[No Abstract] [Full Text] [Related]
19. Treatment of shigellosis with poteseptyl (trimethoprim+superseptyl).
Münnich D; Lakatos M
Chemotherapy; 1974; 20(2):113-9. PubMed ID: 4602936
[No Abstract] [Full Text] [Related]
20. [Study of enteric dysentery vaccines and their efficacy on a rabbit intestinal loop model. II. Changes in the mucosa of rabbit small intestine after oral immunization with live and chemical vaccines].
Polotskiĭ IuE; Rukhamina ML; Krasnoproshina LI; Seliverstova VG; Kolomiets OL
Zh Mikrobiol Epidemiol Immunobiol; 1981 Jan; (1):89-94. PubMed ID: 7015764
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
